Research Analysts’ Price Target Changes for August 11th (AMRZ, GDRX, HCAT, HIMS, IPGP, LUMN, MGY, MNDY, MTDR, OII)

Research Analysts’ price target changes for Tuesday, August 11th:

Amrize (NYSE:AMRZ) had its price target reduced by Citigroup Inc. from $66.00 to $58.00. They currently have a buy rating on the stock.

GoodRx (NASDAQ:GDRX) had its target price increased by Citigroup Inc. from $4.00 to $5.00. The firm currently has a buy rating on the stock.

Health Catalyst (NASDAQ:HCAT) had its price target lowered by Citigroup Inc. from $2.50 to $2.00. Citigroup Inc. currently has a neutral rating on the stock.

Hims & Hers Health (NYSE:HIMS) had its price target lowered by Citigroup Inc. from $35.00 to $33.00. They currently have a neutral rating on the stock.

IPG Photonics (NASDAQ:IPGP) had its price target lowered by Citigroup Inc. from $150.00 to $137.00. They currently have a buy rating on the stock.

Lumen Technologies (NYSE:LUMN) had its target price cut by Citigroup Inc. from $10.00 to $8.25. Citigroup Inc. currently has a neutral rating on the stock.

Magnolia Oil & Gas (NYSE:MGY) had its price target lowered by Citigroup Inc. from $29.00 to $27.00. The firm currently has a neutral rating on the stock.

monday.com (NASDAQ:MNDY) had its target price cut by Citigroup Inc. from $154.00 to $132.00. Citigroup Inc. currently has a buy rating on the stock.

Matador Resources (NYSE:MTDR) had its target price trimmed by Citigroup Inc. from $68.00 to $60.00. The firm currently has a buy rating on the stock.

Oceaneering International (NYSE:OII) had its target price raised by Citigroup Inc. from $40.00 to $52.00. They currently have a neutral rating on the stock.

Olema Pharmaceuticals (NASDAQ:OLMA) had its target price cut by Citigroup Inc. to $59.00. The firm currently has a buy rating on the stock.

Simon Property Group (NYSE:SPG) had its price target raised by LADENBURG THALM/SH SH from $250.00 to $275.00. They currently have a buy rating on the stock.

Zoetis (NYSE:ZTS) had its target price cut by Citigroup Inc. from $112.00 to $96.00. Citigroup Inc. currently has a buy rating on the stock.

Receive News & Ratings for Amrize Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize Ltd and related companies with MarketBeat.com's FREE daily email newsletter.